<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02856074</url>
  </required_header>
  <id_info>
    <org_study_id>BÃ©jot 2015-2</org_study_id>
    <nct_id>NCT02856074</nct_id>
  </id_info>
  <brief_title>Functional Prognosis in Patients With Ischemic Stroke According to the Therapeutic Strategy Used</brief_title>
  <acronym>PARADISE</acronym>
  <official_title>Prognosis After Revascularization Therapy in the Dijon Ischemic Stroke Evaluation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      The current management of ischemic stroke is based on different strategies that may be
      combined: intravenous thrombolysis in a stroke ICU, intravenous thrombolysis in a
      telemedicine procedure, endovascular thrombectomy. Given this now rich therapeutic arsenal,
      it seems necessary to evaluate practices in local care in the field and the impact of these
      on the prognosis of ischemic stroke victims. The aim of this observational study is to
      compare these different care practices without interfering with the choice of strategy.

      A blood sample will also be taken at different times to study the value of growth
      differentiation factors (GDF) 8, 11 and 15, and Brain-derived Neurotrophic Factor as
      prognostic biomarkers
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of handicap</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum levels of biomarkers of stress</measure>
    <time_frame>Changes compared with baseline levels at Day 1, Day 3, Day 7</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Ischemic stroke patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>prise de sang</intervention_name>
    <arm_group_label>Ischemic stroke patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>quality of life questionnaire</intervention_name>
    <arm_group_label>Ischemic stroke patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with symptomatic ischemic stroke defined according to WHO criteria and
             treated by intravenous thrombolysis at the stroke ICU at Dijon CHU, intravenous
             thrombolysis by telemedicine with subsequent transfer to the Dijon stroke ICU, and/or
             endovascular thrombectomy at Dijon CHU)

          -  Patients aged over 18 years.

          -  Patients who have provided written informed consent to take part in the study.

        Exclusion Criteria:

          -  Patients who refuse to take part in the study.

          -  Subjects in custody.

          -  Patients (or a person of trust) who cannot be contacted by telephone during the
             follow-up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yannick BEJOT</last_name>
    <phone>3.80.29.37.53</phone>
    <phone_ext>33</phone_ext>
    <email>yannick.bejot@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick BEJOT</last_name>
      <phone>3.80.29.37.53</phone>
      <phone_ext>33</phone_ext>
      <email>yannick.bejot@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>October 9, 2017</last_update_submitted>
  <last_update_submitted_qc>October 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

